We are thrilled to announce our new partnership with Validaide This collaboration will see SkyMind— SkyCell’s supply chain software platform — integrate with Validaide’s lane risk assessment and ground handling data. This integration will enable pharma companies to make better decisions based on risk, cost, and carbon emissions. Richard Ettl co-founder and CEO of SkyCell, stated: “SkyCell’s vision for pharma has always been zero loss and zero CO₂ emissions for the pharma supply chain. Technology is crucial for decision-makers to reduce costs, risks, and CO₂ emissions in pharma supply chains. Collaboration among stakeholders and technology providers is equally important. Our partnership with Validaide is a significant step forward, empowering pharmaceutical companies to take greater control of their supply chains.” Want to learn more? Read our blog below. https://lnkd.in/e36xbXRS #announcement #partnership #Pharmaceuticalindustry #SkyMind #Supplychain
SkyCell AG
Transport, Logistik, Lieferkette und Lagerhaltung
Zurich, Zurich 24.766 Follower:innen
Safe. Secure. Sustainable.
Info
Welcome to SkyCell, the pioneering Swiss company revolutionizing global pharmaceutical logistics by providing cutting-edge temperature-controlled hybrid containers. Powered by data-driven technology, SkyMind the supply chain operating system, optimizes the pharmaceutical supply chain by reducing and predicting the risk of damaging valuable cargo. With an industry-leading temperature excursion rate of less than 0.05% and a profound reduction in CO2 emissions, our innovative approach has been validated by leading pharma companies and trusted by major airlines. As sustainability remains at the core of our values, SkyCell’s reusable hybrid containers cut CO2 pollution by up to 50% and reduce landfill. With every shipment, we are doing our part to save emissions and chart a positive way forward for the pharma industry. Join us on this transformative journey as we revolutionize the pharma supply chain industry through innovation and sustainability. #SkyCell #PharmaLogistics #TemperatureControlledContainers #InnovationInPharma #SustainabilityInTheSupplyChain #SafeSecureSustainable
- Website
-
http://www.skycell.ch
Externer Link zu SkyCell AG
- Branche
- Transport, Logistik, Lieferkette und Lagerhaltung
- Größe
- 51–200 Beschäftigte
- Hauptsitz
- Zurich, Zurich
- Art
- Privatunternehmen
- Gegründet
- 2013
- Spezialgebiete
- Pharmaceutical Logistics, Biologics Logistics, API Logistics, Temperature Control, Emerging Markets, Shock Reduction, Vibration Reduction, Integrated Temperature Monitoring, Security, Less than 0.1% temperature excursion, Sustainability und Cold Supply Chain
Orte
-
Primär
Hardturmstrasse 11
Zurich, Zurich 8005, CH
-
Gotthardstrasse 28
Zug, ZG 6302, CH
Beschäftigte von SkyCell AG
Updates
-
The pharmaceutical supply chain is complex, requiring meticulous planning to ensure safe, timely delivery of medicines. With threats like temperature excursions and regulatory hurdles, maintaining product integrity during transit is crucial. SkyCell's recent collaboration with Beijing Chemfast on a high-stakes shipment from Beijing to New York showcased the exceptional capabilities of our 1500X #hybridcontainer and SkyMind platform. This success story highlights how SkyCell’s advanced technology and lane risk management ensure critical medicines reach their destinations safely and efficiently. Are you curious about how SkyCell’s cutting-edge solutions can transform your pharmaceutical logistics? Read the full story below! ⤵️ #SkyCell #APAC #coldsupplychain #pharmaceuticalindustry #shipment
Hybrid Containers Ensure Resilient Pharma Shipment from Beijing to New York
SkyCell AG auf LinkedIn
-
Today, pharmaceutical goods account for over 28% of all cargo worldwide. In the latest issue of Global Business Reports (GBR), SkyCell's CEO Richard Ettl, along with Fabrice Panza (from Etihad Cargo) and Julian Sutch (from Emirates SkyCargo), explored the growing demand for high-value pharmaceutical products in the US. They delved into the pivotal role of air freight and underscored the urgency of adopting sustainable solutions. ✈️ Interested in learning more? Read the full interview below. #SupplyChain #Airfreight #Challenges #HybridContainers #Sustainability
-
It’s the beginning of the month, and we are thrilled to introduce our newest team members: Carmen Mihaela Sofinceanu, Freya Foo, Veronika Bass and Sujin Park! A big WELCOME to all of you! 🎉 We are excited to have such talented and enthusiastic individuals join our team. At SkyCell, we are committed to innovation, excellence, and growth, and we believe that each of you will bring unique perspectives and skills to help us achieve even greater heights. Here’s to a fantastic start and a journey filled with opportunities, collaboration, and success! #WeAreSkyCell #NewJoiners #Innovation #Career #hiringnow
-
-
As the pharmaceutical industry transitions from chemical to biological products, more high-value pharmaceutical goods are being shipped in greater quantities worldwide. This transition brings the challenge of optimizing Total Cost of Ownership (TCO) in an already complex supply chain. Balancing cost savings with quality and risk management is already difficult. Now, with the rising need to reduce CO₂ emissions, the TCO equation becomes even more intricate. Therefore, reducing costs, managing risks, and cutting CO₂ emissions simultaneously is a significant challenge. For instance, opting for cheaper packaging might reduce immediate costs but can lead to higher airfreight expenses, increased risks, and greater CO₂ emissions due to suboptimal weight-volume ratios. Addressing these three dimensions - cost, risk, and CO₂ emissions - requires advanced strategies and expertise. Navigating this complex landscape is not easy, but SkyCell’s experts are here to help. Contact us today to learn how we can assist you in optimizing your TCO in the supply chain. https://lnkd.in/ezPxReEJ #Pharmaceuticalindustry #SupplyChainOptimization #RiskManagement #CostEfficiency #ColdChain
-
The transportation of temperature-sensitive medicines presents a significant challenge within the pharmaceutical industry. Maintaining precise temperature control throughout the supply chain is critical for preserving the efficacy and safety of these vital drugs. Moreover, IoT technology simplifies handling by allowing pharmaceutical companies to monitor their supply chain in transit. SkyCell’s supply chain operating system, SkyMind, streamlines shipment and asset management through automation and real-time visibility. Unlock the potential of hybrid containers in revolutionizing pharmaceutical supply chains. Dive into our latest article to discover how they optimize efficiency, ensure secure logistics, and minimize disruptions. Ready to transform your pharmaceutical logistics? #HybridContainers #PharmaceuticalIndustry #SupplyChain #coldchain #Innovation
Hybrid Containers: The Future of Pharma Cold Chain
SkyCell AG auf LinkedIn
-
In our #EmployeeSpotlight series, we delve into the diverse career paths of SkyCell employees. They share inspiring personal stories, career expertise, and a glimpse into what makes our company culture unique. Today, we sat down with Mark Lehmann, VP of Improvement and Quality, to discover his unique journey within the company and gain valuable insights from his experience. Read more below ⤵️ #Career #WeAreSkyCell #CareerGrowth #PersonalDevelopment
SkyCell's Employee Spotlight: Insights from Mark
SkyCell AG auf LinkedIn
-
Exciting news! 🚀 SkyCell is thrilled to announce the closure of its US$116 million Series D funding round, with US$59 million coming from Tybourne Capital Management and CC Industries, Inc (CCI). This follows a US$57 million equity investment from Catalyst, M&G Investments’ purpose-led private assets strategy. The investment will fuel the continued expansion of SkyCell’s global footprint, focusing particularly on growth in the US and Asia. SkyCell’s Chief Financial Officer, Dr. Remo Gerber, commented, “Gaining CCI and Tybourne as investors significantly broadens our footprint in the US and Asia and is testament to our high growth based on strong financial fundamentals. Having established technological foundations in cold chain hardware, software, and IoT-enabled tracking, this investment enables us to commercialize our platform into adjacent pharma market segments, significantly expanding our total addressable market beyond cold chain packaging.” Read the full announcement below: https://lnkd.in/eKzBHHxV... #announcement #fundraising #investors #businessgrowth #Supplychain
-
-
As temperatures increase, how confident are you in your supply chain's resilience to rising temperatures?” The majority of you responded with "measures set, room to improve". As summer approaches and temperatures rise, ensuring the safe transport of temperature-sensitive medications becomes more critical than ever. At SkyCell, we recognize the challenges pharma companies face in maintaining product integrity, especially since traditional methods like dry ice and Styrofoam one-way boxes are often insufficient to ensure efficacy and safety. SkyCell’s self-charging hybrid containers maintain stable temperature conditions, deflect shock absorption, and sustain steady protection under extreme conditions throughout their journey. Our hybrid containers offer an impressive 270-hour independent runtime, ensuring that your medications remain preserved even in the most critical times. With our advanced technology and real-time data monitoring, you can have peace of mind knowing that your pharmaceuticals are protected from any potential disruptions in the supply chain. Learn more about SkyCell's solutions and ensure a smooth, temperature-controlled journey for your medications this season. https://lnkd.in/eJa-cXUr #SupplyChain #Pharmaceuticalindustry #TemperatureControl #ColdChain #HybridContainers
-
-
Last week, we hosted our inaugural event, the "SkyCell Annual Summit", focused on sustainability, in Dusseldorf. 🤩 The event was a great success, featuring a diverse selection of inspiring panel discussions. Our remarkable speakers shared invaluable insights covering supply chain sustainability, including decarbonization, innovation, and advancements in the clinical supply chain. SkyCell’s Summit provided a unique opportunity to connect with industry leaders, experts, and peers, fostering both existing relationships and new connections. We extend our sincere appreciation to all participants, especially our outstanding speakers. Additionally, special thanks go to our Head of Sales EMEA, Radek Samsonowicz, and SkyCell’s event manager, Nathalie Linden, for their dedication in organizing this amazing event. As we look ahead, let's continue to innovate, collaborate, and drive positive change in the pharma supply chain industry, collectively working towards a sustainable future. #SkyCellSummit #Pharmaceuticalindustry #ColdChain #event #Sustainability
-